Gylna Loko

794 total citations
25 papers, 515 citations indexed

About

Gylna Loko is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gylna Loko has authored 25 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 16 papers in Hematology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gylna Loko's work include Hemoglobinopathies and Related Disorders (24 papers), Iron Metabolism and Disorders (12 papers) and Blood groups and transfusion (5 papers). Gylna Loko is often cited by papers focused on Hemoglobinopathies and Related Disorders (24 papers), Iron Metabolism and Disorders (12 papers) and Blood groups and transfusion (5 papers). Gylna Loko collaborates with scholars based in Martinique, France and Guadeloupe. Gylna Loko's co-authors include Frédéric Galactéros, Anoosha Habibi, François Lionnet, Jocelyn Inamo, Laurent Savale, Bernard Maître, Gérald Simonneau, Florence Parent, Dora Bachir and Robert Girot and has published in prestigious journals such as New England Journal of Medicine, Blood and American Journal of Public Health.

In The Last Decade

Gylna Loko

22 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gylna Loko Martinique 7 405 293 140 73 54 25 515
Giorgio Derchi Italy 11 383 0.9× 275 0.9× 124 0.9× 114 1.6× 26 0.5× 21 476
Stergios Tassiopoulos Greece 11 260 0.6× 231 0.8× 157 1.1× 53 0.7× 25 0.5× 16 436
Mannucci Italy 12 207 0.5× 793 2.7× 166 1.2× 43 0.6× 22 0.4× 12 939
Alessia Marcon Italy 13 333 0.8× 273 0.9× 24 0.2× 8 0.1× 80 1.5× 32 416
M.W. Kenny United Kingdom 10 174 0.4× 160 0.5× 157 1.1× 33 0.5× 21 0.4× 20 370
S. Moratelli Italy 11 72 0.2× 256 0.9× 84 0.6× 65 0.9× 9 0.2× 21 400
Gabriela Sciuccati Argentina 13 89 0.2× 328 1.1× 27 0.2× 67 0.9× 38 0.7× 33 458
Alessandro Brunetti Italy 11 76 0.2× 261 0.9× 84 0.6× 25 0.3× 18 0.3× 41 400
Martin Grünewald Germany 11 118 0.3× 212 0.7× 61 0.4× 34 0.5× 5 0.1× 19 384
Ramzi El Accaoui United States 11 72 0.2× 83 0.3× 82 0.6× 216 3.0× 9 0.2× 27 410

Countries citing papers authored by Gylna Loko

Since Specialization
Citations

This map shows the geographic impact of Gylna Loko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gylna Loko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gylna Loko more than expected).

Fields of papers citing papers by Gylna Loko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gylna Loko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gylna Loko. The network helps show where Gylna Loko may publish in the future.

Co-authorship network of co-authors of Gylna Loko

This figure shows the co-authorship network connecting the top 25 collaborators of Gylna Loko. A scholar is included among the top collaborators of Gylna Loko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gylna Loko. Gylna Loko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allali, Slimane, Frédéric Galactéros, Lena Oevermann, et al.. (2024). Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort—Hydroxyurea (ESCORT‐HU) study. American Journal of Hematology. 99(4). 555–561. 4 indexed citations
2.
Mandelbrot, Laurent, Frederic Galactéros, Stéphane Bounan, et al.. (2023). Impact of prenatal corticosteroid therapy on sickle cell disease in pregnant women. International Journal of Gynecology & Obstetrics. 163(1). 243–255. 1 indexed citations
3.
Mandelbrot, Laurent, Frédéric Galactéros, Stéphane Bounan, et al.. (2023). Impact of antenatal corticosteroid therapy on sickle cell disease in pregnant women. American Journal of Obstetrics and Gynecology. 228(1). S487–S488. 1 indexed citations
4.
Elenga, Narcisse, et al.. (2022). Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients. Frontiers in Medicine. 9. 931925–931925. 19 indexed citations
5.
Montalembert, Mariane de, Ersi Voskaridou, Lena Oevermann, et al.. (2021). Real‐Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT‐HU cohort study. American Journal of Hematology. 96(10). 1223–1231. 34 indexed citations
6.
Tshilolo, Léon, et al.. (2021). [Realities for a Sickle Cell Disease Control Strategy in the World Health Organization African Region].. PubMed. 1(1). 4 indexed citations
7.
d’Humières, Thomas, Laurent Savale, Jocelyn Inamo, et al.. (2021). Cardiovascular phenotypes predict clinical outcomes in sickle cell disease: An echocardiography‐based cluster analysis. American Journal of Hematology. 96(9). 1166–1175. 8 indexed citations
9.
Loko, Gylna, et al.. (2020). High blood pressure in adult patients with sickle cell disease: New insight from an ambulatory blood pressure monitoring pilot study. Archives of Cardiovascular Diseases Supplements. 12(1). 138–139.
10.
Tshilolo, Léon, et al.. (2018). Diagnostic tools and follow-up of sickle-cell anemia in Central Africa. Médecine et Santé Tropicales. 28(2). 124–127. 5 indexed citations
11.
Montalembert, Mariane de, Gylna Loko, Valentine Brousse, et al.. (2017). Off-Label Prescription of Hydroxycarbamide (Hydroxyurea, HU) for Severe Anemia: Preliminary Results from European Non-Interventional, Multicentric, Prospective Escort-HU Study. Blood. 130(Suppl_1). 758–758. 1 indexed citations
12.
Knight‐Madden, Jennifer, Marc Romana, Marvin Reid, et al.. (2016). CAREST—Multilingual Regional Integration for Health Promotion and Research on Sickle Cell Disease and Thalassemia. American Journal of Public Health. 106(5). 851–853. 6 indexed citations
14.
Stojanovic, Katia Stankovic, Emmanuel Gordien, Jean‐Antoine Ribeil, et al.. (2013). Connaissance de leur maladie des patients drépanocytaires adultes vivant en France : étude multicentrique sur 369 patients. La Revue de Médecine Interne. 34. A46–A47.
15.
Messonnier, Laurent A., Abdoulaye Samb, Julien Tripette, et al.. (2012). Moderate endurance exercise is not a risk for rhabdomyolysis or renal failure in sickle cell trait carriers. Clinical Hemorheology and Microcirculation. 51(3). 193–202. 6 indexed citations
16.
Loko, Gylna, et al.. (2011). Évaluation de la sexualité chez les patients afro-caribéens drépanocytaires homozygotes SS suivis en Martinique. Progrès en Urologie. 22(5). 301–306. 4 indexed citations
17.
Parent, Florence, Dora Bachir, Jocelyn Inamo, et al.. (2011). A Hemodynamic Study of Pulmonary Hypertension in Sickle Cell Disease. New England Journal of Medicine. 365(1). 44–53. 350 indexed citations
18.
Loko, Gylna, et al.. (2010). Association of the +874 T/A interferon gamma polymorphism with infections in sickle cell disease. International Journal of Immunogenetics. 37(4). 219–223. 5 indexed citations
19.
Tripette, Julien, Gylna Loko, Abdoulaye Samb, et al.. (2010). Effects of hydration and dehydration on blood rheology in sickle cell trait carriers during exercise. American Journal of Physiology-Heart and Circulatory Physiology. 299(3). H908–H914. 43 indexed citations
20.
Bachir, Dora, Florence Parent, Jocelyn Inamo, et al.. (2009). Prospective Multicentric Survey On Pulmonary Hypertension (PH) in Adults with Sickle Cell Disease.. Blood. 114(22). 572–572. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026